Biosyent (TSXV:RX) Purchase Of Investment : C$-1.61 Mil (TTM As of Mar. 2024)

View and export this data going back to 1979. Start your Free Trial

What is Biosyent Purchase Of Investment?

Biosyent's purchase of investment for the three months ended in Mar. 2024 was C$-1.61 Mil. It means Biosyent spent C$1.61 Mil on purchasing investments. Biosyent's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was C$-1.61 Mil.

Compared with last quarter (C$0.00 Mil in Dec. 2023 ), Biosyent spent more money on purchasing investments in Mar. 2024 (C$-1.61 Mil).

Biosyent Purchase Of Investment Historical Data

The historical data trend for Biosyent's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyent Purchase Of Investment Chart

Biosyent Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Investment

Get a 7-Day Free Trial

-0.94

-4.89

-10.66

-2.50

Biosyent Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Purchase Of Investment	Get a 7-Day Free Trial															-	-	-	-	-1.61

Biosyent Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.61 Mil.

Biosyent Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Biosyent's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyent (TSXV:RX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (TSXV:RX) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

BIOYF:USA

Address

2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1

Website

http://www.biosyent.com

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.

Executives

Peter Douglas Lockhard

Director

Biosyent (TSXV:RX) Headlines

No Headlines